Atro Medical

Atro Medical is a pioneering orthopedic company focused on addressing the unmet need for post-meniscectomy pain through its innovative Artimis® artificial meniscus prosthesis. The company, founded in 2016 by orthopedic surgeon Dr. Tony van Tienen, has achieved significant regulatory recognition, including FDA Breakthrough Device Designation and an EIC Accelerator grant. Currently in the clinical research phase with studies underway at leading Dutch hospitals, Atro Medical recently secured €3 million in funding to advance toward pivotal studies, positioning it as a leader in the emerging field of meniscus replacement.

Synthetic polymer-based artificial meniscus prosthesis (Artimis®) designed to replace damaged or removed meniscus tissue, aiming to restore knee function and alleviate pain.

The competitive landscape includes companies developing meniscal allografts, collagen scaffolds (e.g., Menaflex), and other synthetic implants. Atro Medical differentiates with a focus on a total synthetic replacement for both medial and lateral menisci and has achieved notable regulatory recognition early in its development.